IRIDEX (IRIX)
(Real Time Quote from BATS)
$2.78 USD
-0.09 (-3.14%)
Updated Apr 29, 2024 03:57 PM ET
4-Sell of 5 4
F Value B Growth B Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
IRIX 2.78 -0.09(-3.14%)
Will IRIX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for IRIX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IRIX
Iridex (IRIX) Reports Q4 Loss, Lags Revenue Estimates
Zacks Industry Outlook Highlights MicroVision, Cutera and IRIDEX
IRIX: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Laser Systems Stocks to Watch in a Challenging Industry
IPG Photonics (IPGP) Q4 Earnings Miss Estimates
IPG Photonics (IPGP) Q3 Earnings Surpass Estimates
Other News for IRIX
Iridex's Strategic Review Process Should Bear Fruit 'Soon'
12 Health Care Stocks Moving In Thursday's After-Market Session
Analysts Have Conflicting Sentiments on These Healthcare Companies: Argenx Se (ARGX), Iridex (IRIX) and Keros Therapeutics (KROS)
Iridex: Q4 Earnings Snapshot
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results